Novel phosphoramidate derivatives of the anti-HIV nucleoside analogues AZT and d4T have been prepared by phosphorochloridate chemistry. These materials are designed to act as labile membrane-soluble prodrugs of the bio-active free nucleotides. All compounds were fully characterised by a range of methods and were subjected to evaluation in vitro of their anti-HIV efficacy. A notable feature of the current study was that any attempt to replace the amino acid moiety of the phosphoramidate with a simple amine lead to a marked, virtually total loss of activity. Such simple phenyl alkylamino phosphate derivatives of either d4T or AZT inhibit HIV replication at cytotoxic concentrations and have no detectable antiviral selectivity. This clearly highlights the vital role played by the amino acid in the antiviral efficacy of the blocked phosphoramidates.
BalzariniJ.KarlssonA.Perez-PerezM.-J.CamarasaM.-J.TarpleyW.G., and De ClercqE. (1993) Treatment of human immunodeficiency virus type 1 (HIV-1)-infected cells with combinations of HIV-1-specific inhibitors results in a different resistance pattern than does treatment with single-drug therapy. J Virology67: 5353–5359.
2.
DessauxC., and Huynh-DinhT. (1993) Synthesis of phosphodiester and triester derivatives of AZT with tethered Nmethyl piperazine and N,N,N trimethylethylenediamine. Biorg Med Chem Lett3: 1547–1550.
3.
FarrowS.N.JonesA.S.KumarA.WalkerR.T.BalzariniJ., and De ClercqE. (1990) Synthesis and biological properties of novel phosphotriesters: A new approach to the introduction of biologically active nucleotides into cells. J Med Chem33: 1400–1406.
4.
FranchettiP.CappellacciL.GrifantiniM.MessiniL.SheikhaG.A.LoiA.G.TramontanoE.De MontisA.SpigaM.G., and la CollaP. (1994) Synthesis and evaluation of the anti-HIV activity of aza and deaza analogues of isoddA and their phosphates as prodrugs. J Med Chem37: 3534–3541.
5.
FreedJ.FarquharD., and HamptonA. (1989) Evidence for acyloxymethyl esters of pyrimidine 5′-deoxyribonucleotides as extracellular sources of active 5′-deoxyribonucleotides in cultured cells. Biochem Pharmacol38: 3193–3198.
6.
HeninY.GouyetteC.SchwartzO.DebouzyJ.-C.NeumannJ.-M., and Huynh-DinhT. (1991) Lipophilic glycosyl phosphotriester derivatives of AZT: Synthesis, NMR transmembrane transport study and antiviral activity. J Med Chem34: 1830–1837.
7.
MarkV.DunganC.H.CrutchfieldM.M., and van WazerJ.R. (1969) Compilation of 31P NMR data. In Topics in Phosphorus Chemistry, vol. 5. GraysonM., and GriffithE. J. (eds). New York, Wiley. pp. 350–360.
8.
McGuiganC.NichollsS.R.O'ConnorT.J., and KinchingtonD. (1990a) Synthesis of some novel dialkylphosphate derivatives of 3′-modified nucleosides as potential anti-AIDS drugs. Antiviral Chem Chemother1: 25–33.
9.
McGuiganC.O'ConnorT.J.NichollsS.R.NicksonC., and KinchingtonD. (1990b) Synthesis and anti-HIV activity of some novel substituted dialkyl phosphate derivatives of AZT and ddCyd. Antiviral Chem Chemother1: 355–360.
10.
McGuiganC.DevineK.G.O'ConnorT.J.GalpinS.A.JeffriesD.J., and KinchingtonD. (1990c) Synthesis and evaluation of some novel phosphoramidate derivatives of 3′-azido-3′-deoxythymidine. Antiviral Chem Chemother1: 107–113.
11.
McGuiganC.DevineK.G.O'ConnorT.J., and KinchingtonD. (1991) Synthesis and anti-HIV activity of some haloalkyl phosphoramidate derivatives of 3′-azido-3′-deoxythymidine (AZT): potent activity of the trichloroethyl methoxyalaninyl compound. Antiviral Res15: 255–263.
12.
McGuiganC.PathiranaR.N.MahmoodN.DevineK.G., and HayA.J. (1992) Aryl phosphate derivatives of AZT retain activity against HIV1 in cell lines which are resistant to the action of AZT. Antiviral Res17: 311–321.
13.
McGuiganC.PathiranaR.N.BalzariniJ., and De ClercqE. (1993a) Intracellular delivery of bio-active AZT nucleotides by aryl phosphate derivatives of AZT. J Med Chem36: 1048–1052.
14.
McGuiganC.SheekaH.M.MahmoodN., and HayA. (1993b) Phosphate derivatives of d4T as inhibitors of HIV. Bioorg Med Chem Lett3: 1203–1206.
15.
McGuiganC.PathiranaR.N.ChoiS.S.-M.KinchingtonD., and O'ConnorT.J. (1993c) Phosphoramidate derivatives of AZT as inhibitors of HIV: studies on the carboxyl terminus. Antiviral Chem Chemother4: 97–101.
16.
McGuiganC.PathiranaR.N.DaviesM.P.H.BalzariniJ., and De ClercqE. (1994a) Diaryl phosphate derivatives act as pro-drugs of AZT with reduced cytotoxicity compared to the parent nucleoside. Bioorg Med Chem Lett4: 427–430.
17.
McGuiganC.BellevergueP.SheekaH.MahmoodN., and HayA.J. (1994b) Certain phosphoramidate derivatives of dideoxy uridine (ddU) are active against HIV and successfully By-pass thymidine kinase. FEBS Lett351: 11–14.
18.
McGuiganC.CahardD.SheekaH.M.De ClercqE., and BalzariniJ. (1996). Phosphoramidate derivatives of d4T with improved anti-HIV efficacy retain full activity in thymidine kinase-deficient cells. Bioorg Med Chem Lett (in press).
19.
NamaneA.GouyetteC.FillionM.-P.FillionG., and Huynh-DinhT. (1992) Improved brain delivery of AZT using a glycosyl phosphotriester prodrug. J Med Chem35: 3039–3044.
